ASH 2025 Lymphoma Highlights: Epcoritamab, S1826, Mosunetuzumab & ctDNA | Dr. Sworder ASH 6 Mins Read Published: February 2, 2026Author: Dr. Brian Sworder, MD | City of HopeCategory: ASH 2025 | Lymphoma | Precision Oncology |…
Brentuximab v. Nivolumab cHL SWOG S1826 [Slides] Brem, MD – MOASC Non-Hodgkin Lymphoma 4 Mins Read Updates in Lymphoma: Advancements in Treatment Strategies Date: August 12, 2023Presenter: Elizabeth Brem, MD (Clinical Associate Professor) In the ever-evolving…
